Saturday 17 October 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
222.66
1.67
−0.74%
Follow STE
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 8 | 8 | 8 | 3 | 4 | 5 | 7 | 8 | 9 |
P/E ratio |
54.27 | 26.54 | 35.30 | 29.10 | 41.05 | 99.91 | 175.49 | 57.71 | 36.38 | 27.78 |
Altman Z-Score |
2.79 | 3.60 | 4.77 | 4.99 | 4.91 | 3.75 | 3.45 | 3.99 | 5.07 | 5.10 |
P/S ratio |
2.27 | 2.95 | 3.87 | 3.92 | 5.22 | 5.58 | 4.20 | 4.25 | 4.09 | 3.66 |
Altman Z″-Score (non-manufacturers) |
3.18 | 3.68 | 3.94 | 4.30 | 3.68 | 2.81 | 3.11 | 3.67 | 3.97 | 4.50 |
P/FCF ratio |
23.19 | 26.30 | 30.33 | 31.21 | 35.99 | 59.10 | 46.57 | 35.20 | 28.39 | 22.09 |
P/Operating CF |
44.08 | 59.64 | 60.24 | 59.56 | 86.39 | 137.31 | 88.38 | 85.69 | 85.69 | 64.74 |
Beneish M-Score |
(2.79) | (2.47) | (2.67) | (2.58) | (2.65) | (2.44) | (2.47) | (2.56) | (2.59) | (2.68) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 86 |
P/B ratio |
2.11 | 2.41 | 3.38 | 3.47 | 4.17 | 3.60 | 3.13 | 3.46 | 3.38 | 3.02 |
Price to Tangible BV |
0.00 | 136.93 | 41.73 | 23.89 | 0.00 | 0.00 | 145.30 | 174.21 | 33.57 | 15.71 |
EV/Sales |
2.73 | 3.38 | 4.22 | 4.20 | 5.69 | 6.23 | 4.84 | 4.83 | 4.44 | 3.91 |
EV/EBITDA |
15.09 | 15.31 | 18.43 | 17.32 | 23.04 | 23.98 | 16.24 | 17.66 | 18.04 | 14.61 |
EV/Operating CF |
16.82 | 19.35 | 21.76 | 21.53 | 25.64 | 38.44 | 28.99 | 25.52 | 21.10 | 17.30 |
EV/FCF |
27.86 | 30.09 | 33.04 | 33.45 | 39.21 | 65.97 | 53.57 | 40.03 | 30.77 | 23.61 |
Quick Ratio |
2.01 | 1.83 | 1.69 | 1.80 | 1.44 | 1.24 | 1.25 | 1.31 | 1.19 | 1.34 |
Current Ratio |
2.67 | 2.48 | 2.27 | 2.43 | 2.10 | 2.04 | 2.33 | 3.08 | 1.96 | 2.09 |
Net Debt/EBITDA |
2.53 | 1.93 | 1.51 | 1.16 | 1.89 | 2.50 | 2.12 | 2.13 | 1.39 | 0.94 |
Debt/Assets |
30.02% | 25.31% | 23.32% | 21.51% | 25.46% | 27.03% | 28.45% | 28.98% | 20.14% | 17.99% |
Debt/Equity |
0.53 | 0.41 | 0.37 | 0.34 | 0.43 | 0.47 | 0.51 | 0.51 | 0.31 | 0.27 |
Asset Turnover |
0.51 | 0.52 | 0.54 | 0.58 | 0.52 | 0.47 | 0.41 | 0.47 | 0.51 | 0.57 |
Operating CF/Net income |
3.86 | 1.57 | 1.78 | 1.45 | 1.74 | 2.81 | 7.07 | 2.57 | 1.87 | 1.71 |
Capex/Depreciation |
(0.68) | (0.92) | (0.82) | (1.07) | (1.09) | (0.46) | (0.62) | (0.62) | (0.76) | (0.74) |
Interest Coverage |
5.08 | 7.90 | 9.13 | 13.33 | 14.75 | 5.34 | 7.33 | 5.79 | 10.04 | 18.15 |
| 3.76% | 9.65% | 9.49% | 12.35% | 10.87% | 4.67% | 1.69% | 6.10% | 9.51% | 11.33% | |
| 2.14% | 5.75% | 5.91% | 7.75% | 6.61% | 2.71% | 0.96% | 3.46% | 5.80% | 7.49% | |
ROIC |
3.53% | 5.77% | 6.19% | 7.86% | 6.41% | 3.22% | 5.52% | 5.61% | 6.38% | 7.92% |
Return on Tangible Assets |
7.08% | 18.16% | 18.75% | 22.25% | 21.26% | 9.72% | 3.85% | 10.21% | 20.94% | 22.94% |
Average Days of Receivables |
67.54 | 73.57 | 74.10 | 70.63 | 71.58 | 69.06 | 69.60 | 71.62 | 69.80 | 67.20 |
Research and Development Expense of Revenue |
2.27% | 2.32% | 2.27% | 2.16% | 2.13% | 2.05% | 2.17% | 2.02% | 1.97% | 1.90% |
Selling, General and Administrative Expense of Revenue |
26.10% | 24.12% | 24.08% | 23.65% | 23.53% | 31.22% | 24.04% | 24.37% | 24.44% | 23.72% |
Intangible Assets out of Total Assets |
0.60 | 0.61 | 0.58 | 0.54 | 0.60 | 0.68 | 0.55 | 0.56 | 0.59 | 0.54 |
Share Based Compensation of Revenue |
0.72% | 0.85% | 0.86% | 0.79% | 0.84% | 1.37% | 0.86% | 1.10% | 1.05% | 1.04% |
Graham Net Nets |
(0.18) | (0.13) | (0.08) | (0.07) | (0.09) | (0.13) | (0.14) | (0.09) | (0.07) | (0.05) |
Graham Number |
30.77 | 54.04 | 55.31 | 66.06 | 69.05 | 60.45 | 38.69 | 74.22 | 96.98 | 114.57 |
Earnings Yield |
1.84% | 3.77% | 2.83% | 3.44% | 2.44% | 1.00% | 0.57% | 1.73% | 2.75% | 3.60% |
Free Cash Flow Yield |
4.31% | 3.80% | 3.30% | 3.20% | 2.78% | 1.69% | 2.15% | 2.84% | 3.52% | 4.53% |
Revenue per Share |
30.57 | 30.81 | 32.90 | 35.75 | 36.47 | 43.30 | 45.50 | 52.01 | 55.37 | 60.45 |
Operating CF per Share |
4.96 | 5.38 | 6.38 | 6.97 | 8.09 | 7.02 | 7.59 | 9.85 | 11.64 | 13.66 |
Capex per Share |
(1.97) | (1.92) | (2.18) | (2.48) | (2.80) | (2.93) | (3.48) | (3.57) | (3.66) | (3.65) |
Free Cash Flow per Share |
3.00 | 3.46 | 4.20 | 4.48 | 5.29 | 4.09 | 4.11 | 6.28 | 7.98 | 10.01 |
Cash per Share |
3.31 | 2.37 | 2.61 | 3.77 | 2.59 | 3.57 | 2.09 | 2.10 | 1.74 | 4.48 |
Shareholders Equity per Share |
32.88 | 37.84 | 37.67 | 40.32 | 45.67 | 67.10 | 61.05 | 63.92 | 67.10 | 73.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
32.88 | 37.84 | 37.67 | 40.32 | 45.67 | 67.10 | 61.05 | 63.92 | 67.10 | 73.29 |
Free Cash Flow |
256.03 | 294.27 | 355.36 | 380.20 | 450.95 | 398.99 | 409.57 | 620.40 | 787.20 | 982.90 |
Working Capital |
636.22 | 591.20 | 588.54 | 720.43 | 633.83 | 956.78 | 1,149.60 | 1,938.00 | 978.60 | 1,249.60 |
Capital Expenditures |
(168.05) | (163.36) | (184.15) | (210.36) | (238.69) | (285.82) | (347.38) | (352.90) | (360.90) | (358.50) |
Net Current Asset Value |
(1,096.62) | (993.38) | (833.54) | (798.62) | (1,471.25) | (2,999.96) | (2,723.22) | (1,879.23) | (1,530.30) | (1,145.40) |
EV/EBIT |
31.53 | 22.14 | 28.56 | 23.68 | 32.25 | 55.09 | 27.74 | 29.71 | 27.95 | 21.06 |
Capex to Sales |
0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.07 | 0.08 | 0.07 | 0.07 | 0.06 |
Price to Operating Income |
26.25 | 19.35 | 26.22 | 22.10 | 29.60 | 49.35 | 24.11 | 26.12 | 25.79 | 19.71 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.27 | 0.18 | 0.22 | 0.18 | 0.18 | 0.40 | 0.34 | 0.32 | 0.24 | 0.23 |
Cash ROIC |
5.60% | 6.21% | 7.74% | 7.75% | 7.79% | 4.00% | 4.37% | 6.38% | 8.91% | 10.27% |
Accounts Receivable Turnover |
5.47 | 5.18 | 5.09 | 5.27 | 5.20 | 6.00 | 5.45 | 5.49 | 5.32 | 5.56 |
Accounts Payable Turnover |
11.62 | 11.34 | 11.13 | 11.32 | 11.52 | 12.23 | 10.43 | 11.32 | 11.48 | 10.68 |
Inventory Turnover |
8.12 | 7.57 | 7.76 | 7.25 | 6.10 | 5.26 | 4.33 | 4.57 | 4.87 | 5.46 |
Average Days of Payables |
30.71 | 32.47 | 34.73 | 31.86 | 32.47 | 35.21 | 37.73 | 31.46 | 33.53 | 37.37 |
Days of Inventory on Hand |
45.51 | 49.17 | 47.29 | 56.22 | 65.18 | 89.67 | 86.33 | 84.30 | 69.41 | 69.68 |
Average Receivables |
477.49 | 505.76 | 546.45 | 575.66 | 597.94 | 704.22 | 832.01 | 936.65 | 1,026.16 | 1,068.40 |
Average Payables |
136.53 | 134.67 | 144.39 | 151.13 | 153.15 | 191.34 | 244.95 | 257.94 | 266.26 | 309.80 |
Average Inventory |
195.31 | 201.78 | 206.99 | 235.89 | 289.31 | 445.03 | 589.70 | 639.47 | 627.92 | 606.55 |
Average Assets |
5,135.44 | 5,062.39 | 5,136.70 | 5,256.97 | 6,007.67 | 8,999.03 | 11,122.72 | 10,942.77 | 10,605.25 | 10,442.00 |
Average Common Equity |
2,924.45 | 3,013.65 | 3,201.54 | 3,302.00 | 3,654.84 | 5,218.05 | 6,315.90 | 6,201.26 | 6,465.57 | 6,906.55 |
Columns are period end dates